Coverage Includes:
-
microRNA Mechanism and Targets
-
Role of microRNA in Cancer, HIV, and Behavior
-
Impact of Polymorphisms in microRNA Targets
-
microRNA Screening to Identify Function
-
microRNA Expression Profiling
-
microRNA as Diagnostic Biomarkers
-
microRNA as Targets for Therapeutic Development
Event Features:
- Comprehensive coverage of the latest developments in microRNA, focused exclusively on human studies
- Pre-conference tutorial on microRNA assays and analysis platforms
- Meeting bridges academic and pharmaceutical/biotechnology communities
- Focused trade show and technology showcase brings the newest microRNA tools
- Poster session expands the scientific content
Distinguished Faculty
- Reuven Agami, The Netherlands Cancer Institute
- Michael R. Barnes, GlaxoSmithKline
- George Calin, Ohio State University
- Ayelet Chayut, Rosetta Genomics
- Dalia Cohen, Rosetta Genomics
- Tim Davison, Asuragen
- Henry M. Furneaux, University of
Connecticut Medical School
- Aimee Jackson, Rosetta Inpharmatics, Merck
- Sakari Kauppinen, University of Copenhagen
- Anna M. Krichevsky, Harvard Medical School
- Jun Lu, Broad Institute
- Muthiah Manoharan, Alnylam Pharmaceuticals
- John Rossi, Beckman Research Institute of the
City of Hope
- Neil Smalheiser, University of Illinois, Chicago
- Giovanni Stefani, Frank Slack Lab, Yale University
- Edwin Wang, National Research Council Canada
-
Lin Zhang, University of Pennsylvania School of Medicine
|
Register
by February 23
&
Save up to $200!
Arrive Early!
Attend
the
miRNA Analysis:
From Sample to Discovery
Pre-Conference Tutorial
When: March 29
9:00am - 12:00pm
For more information
please contact:
Julia Boguslavsky, Conference
Director
For exhibit & sponsorship information,
please contact:
Carol
Dinerstein at 781-972-5471
|
